Globe Life (NYSE:GL) CFO Sells $1,792,315.80 in Stock

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 11,790 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $152.02, for a total transaction of $1,792,315.80. Following the completion of the transaction, the chief financial officer owned 40,972 shares of the company’s stock, valued at $6,228,563.44. This trade represents a 22.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05.

Globe Life Price Performance

Shares of GL stock opened at $154.44 on Friday. The company has a market capitalization of $11.99 billion, a PE ratio of 10.68 and a beta of 0.50. The firm has a fifty day simple moving average of $145.76 and a 200-day simple moving average of $141.04. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a twelve month low of $116.73 and a twelve month high of $156.69.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). The firm had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. Globe Life’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the company posted $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities research analysts anticipate that Globe Life Inc. will post 15.56 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. Globe Life’s dividend payout ratio is 9.13%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in GL. Norges Bank bought a new position in Globe Life during the 4th quarter valued at $155,617,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after buying an additional 879,391 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Globe Life by 98.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after buying an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in shares of Globe Life in the 3rd quarter worth about $80,925,000. Finally, Westfield Capital Management Co. LP bought a new position in shares of Globe Life in the 3rd quarter worth about $61,569,000. 81.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently weighed in on GL. Truist Financial upped their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Evercore set a $157.00 target price on shares of Globe Life in a research note on Wednesday, February 18th. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. Finally, Wells Fargo & Company increased their price objective on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, April 10th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $172.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.